Navigation Links
Pharm MD Solutions Becomes an ASCP MTM Provider Partner
Date:11/20/2007

PHILADELPHIA, Nov. 20 /PRNewswire-USNewswire/ -- The American Society of Consultant Pharmacists (ASCP) announces that PharmMD Solutions has become one of ASCP's Medication Therapy Management (MTM) Provider Partners. This announcement was made today at Senior Care Pharmacy '07 - ASCP's 38th Annual Meeting and Exhibition taking place in Philadelphia.

The need for skilled clinicians to deliver MTM services has increased dramatically since the coverage of MTM services under Medicare Part D, especially for patients residing outside of nursing facilities. Our MTM Provider Partners, recognizing the excellence of ASCP members, turned to the Society to help them enlist consultant and senior care pharmacists to deliver MTM services to their contracted enrollees.

Consultant and senior care pharmacists are clinicians specially trained in geriatric pharmacotherapy who review patients' medication regimens to ensure they are receiving the most appropriate, safe, and most effective medications, and that they are used appropriately. Further, consultant and senior care pharmacists identify individuals at high risk for medication-related problems, and identify and resolve health problems that are not otherwise recognized as medication-related.

"This new partnership will expand the reach of ASCP member consultant and senior care pharmacists into community-based settings, bringing much needed clinical expertise to medically complex patients wherever they reside," said ASCP Executive Director & CEO John Feather.

PharmMD Solutions specializes in delivering MTM services to patients covered under groups such as employer sponsored health benefits, government entities, health plans, union funds, pharmacy benefits managers, disease management firms, case management companies, and managed care organizations.

"In line with our mission of making health care personal, we are passionate about positively impacting individual lives through improved medication use," said Brad Tice, Chief Clinical Officer of PharmMD Solutions. "We are excited to partner with ASCP and its highly qualified clinician members to provide quality, personal MTM services and help maximize the number of MTM opportunities delivered across the country by pharmacists - the medication experts."

"ASCP's MTM Provider Partners offer our members a unique path for providing clinical services in the community setting," said ASCP's Feather. "This has been a membership desire for some time, and we are pleased to add ASCP's MTM Provider Partners to our roster of member benefits."

The American Society of Consultant Pharmacists, the recognized expert in geriatric pharmacotherapy, is the international professional association that provides leadership, education, advocacy, and resources to advance the practice of consultant and senior care pharmacy. ASCP's 8,000 members manage and improve drug therapy and improve the quality of life of geriatric patients and other individuals residing in a variety of environments, including nursing facilities, subacute care and assisted living facilities, psychiatric hospitals, hospice programs, and in-home and community-based care. Visit ASCP's Web site at http://www.ascp.com.


'/>"/>
SOURCE American Society of Consultant Pharmacists
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
5. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
6. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
8. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
9. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
10. Simcere Pharmaceutical Group Acquires a 51% Stake in Boda Pharmaceutical Co., Ltd.
11. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... ... squash, announced it has enlisted New York City-based sports and entertainment marketing firm ... and procure sponsorship opportunities for the Professional Squash Association (PSA), which includes first-time ...
(Date:3/29/2017)... MD (PRWEB) , ... March 30, 2017 , ... CHARM ... Charm City Run has announced that Mercy Medical Center will serve as the official ... the Mid-Atlantic region. On Sunday, June 25, 2017, thousands of women will walk or ...
(Date:3/29/2017)... ... March 30, 2017 , ... Sports Brand EXOUS Bodygear announced today ... normally at $29.97; for the remaining days of March, the price will be only ... a special price of just $10 (regular retail price $19.97). , The special promotional ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... services with or without a referral to new patients from Burnaby, BC. Patients ... or other full mouth reconstruction services, can see the esteemed team at Wall ...
(Date:3/29/2017)... Horeb, WI (PRWEB) , ... March 29, 2017 , ... ... patients on early orthodontic treatment and accepting new pediatric patients, with or without a ... help young patients have a better orthodontic outcome and experience. When patients receive early ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 29, 2017  Novartis announced today that the ... the company,s Biologics License Application (BLA) filing and ... chimeric antigen receptor T cell (CAR-T) therapy, in ... patients with B-cell acute lymphoblastic leukemia (ALL). This ... a CAR-T. The priority review designation is expected ...
(Date:3/29/2017)... DES MOINES, Iowa , March 29, 2017 ... Iowa Lt. Gov. Kim Reynolds , Department of Public ... Control Policy Director Steve Lukan in announcing the ... at all CVS Pharmacy locations in Iowa.  CVS Health has ... that allows CVS Pharmacy to expand access to ...
(Date:3/29/2017)... Research and Markets has announced the addition of the "South ... & Forecast" report to their offering. ... The South Korean Proton Therapy Market is expected to ... Untapped Proton Therapy Market for South Korea was ... Proton Therapy plays an important role in delivering comprehensive cancer care to ...
Breaking Medicine Technology: